Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

New perspectives on screening and early detection of endometrial cancer.

Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pavón MÁ, Martínez JM, Climent M, Barahona M, Canet J, Paytubi S, Salinas M, Palomero L, Bianchi I, Reventós J, Capellà G, Diaz M, Vidal A, Piulats JM, Aytés Á, Ponce J, Brunet J, Bosch FX, Matias-Guiu X, Alemany L, de Sanjosé S; Screenwide Team.

Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32514. [Epub ahead of print] Review.

PMID:
31199503
2.

Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.

Martínez-Gómez X, Curran A, Campins M, Alemany L, Rodrigo-Pendás JÁ, Borruel N, Castellsagué X, Díaz-de-Heredia C, Moraga-Llop FA, Del Pino M, Torné A.

Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1700857.

3.

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.

Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, Zuna R, Schiffman M, Mirabello L.

Papillomavirus Res. 2019 Jun;7:67-74. doi: 10.1016/j.pvr.2019.02.001. Epub 2019 Feb 6.

4.

Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort.

Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O, Quirós B, Pavon MA, Taberna M, Alemany L, Servitje O, Mena M.

PLoS One. 2019 Jan 16;14(1):e0210070. doi: 10.1371/journal.pone.0210070. eCollection 2019.

5.

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.

Taberna M, Torres M, Alejo M, Mena M, Tous S, Marquez S, Pavón MA, León X, García J, Guix M, Hijano R, Bonfill T, Aguilà A, Lozano A, Mesía R, Alemany L, Bravo IG.

Front Oncol. 2018 Dec 11;8:589. doi: 10.3389/fonc.2018.00589. eCollection 2018.

6.

Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.

Kim YT, Serrano B, Lee JK, Lee H, Lee SW, Freeman C, Oh JK, Alemany L, Bosch FX, Bruni L.

Papillomavirus Res. 2019 Jun;7:26-42. doi: 10.1016/j.pvr.2018.12.002. Epub 2018 Dec 30.

7.

Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.

Mena M, Taberna M, Monfil L, Arbyn M, de Sanjosé S, Bosch FX, Alemany L, Bruni L.

J Infect Dis. 2019 Apr 19;219(10):1574-1585. doi: 10.1093/infdis/jiy715.

8.

Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.

Lop J, García J, López M, Taberna M, Mena M, Alemany L, Quer M, León X.

Head Neck. 2019 May;41(5):1328-1334. doi: 10.1002/hed.25559. Epub 2018 Dec 14.

PMID:
30549389
9.

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.

Hermida-Prado F, Menéndez ST, Albornoz-Afanasiev P, Granda-Diaz R, Álvarez-Teijeiro S, Villaronga MÁ, Allonca E, Alonso-Durán L, León X, Alemany L, Mena M, Del-Rio-Ibisate N, Astudillo A, Rodríguez R, Rodrigo JP, García-Pedrero JM.

J Clin Med. 2018 Dec 1;7(12). pii: E501. doi: 10.3390/jcm7120501.

10.

Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.

Pimenoff VN, Tous S, Benavente Y, Alemany L, Quint W, Bosch FX, Bravo IG, de Sanjosé S.

Int J Cancer. 2019 May 15;144(10):2478-2488. doi: 10.1002/ijc.31964. Epub 2018 Dec 11.

PMID:
30387873
11.

HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival.

Taberna M, Mena M, Tous S, Pavón MA, Oliva M, León X, Garcia J, Guix M, Hijano R, Bonfill T, Aguilà A, Alemany L, Mesía R.

PLoS One. 2018 Apr 17;13(4):e0194107. doi: 10.1371/journal.pone.0194107. eCollection 2018.

12.

Comparative assessment of HPV, alcohol and tobacco etiological fractions in Algerian patients with laryngeal squamous cell carcinoma.

Kariche N, Hortal MT, Benyahia S, Alemany L, Moulaï N, Clavero O, Muñoz M, Ouahioune W, Djennaoui D, Touil-Boukoffa C, de Sanjosé S, Bourouba M.

Infect Agent Cancer. 2018 Mar 13;13:8. doi: 10.1186/s13027-018-0181-x. eCollection 2018.

13.

Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.

Alejo M, Alemany L, Clavero O, Quiros B, Vighi S, Seoud M, Cheng-Yang C, Garland SM, Juanpere N, Lloreta J, Tous S, Klaustermeier JE, Quint W, Bosch FX, de Sanjosé S, Lloveras B; RIS HPV TT study group.

Papillomavirus Res. 2018 Jun;5:134-142. doi: 10.1016/j.pvr.2018.03.005. Epub 2018 Mar 17.

14.

Differentiated Vulvar Intraepithelial Neoplasia-like and Lichen Sclerosus-like Lesions in HPV-associated Squamous Cell Carcinomas of the Vulva.

Rakislova N, Alemany L, Clavero O, Del Pino M, Saco A, Quirós B, Lloveras B, Alejo M, Halec G, Quint W, de Sanjosé S, Ordi J; VVAP study group.

Am J Surg Pathol. 2018 Jun;42(6):828-835. doi: 10.1097/PAS.0000000000001047.

15.

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L.

Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20.

PMID:
29496041
16.

The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.

Abrahão R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcatova I, Betka J, Merletti F, Richiardi L, Kjaerheim K, Serraino D, Polesel J, Simonato L, Alemany L, Agudo Trigueros A, Macfarlane TV, Macfarlane GJ, Znaor A, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner M, Cadoni G, Boccia S, Gheit T, Tommasino M, Scelo G, Brennan P.

Int J Cancer. 2018 Jul 1;143(1):32-44. doi: 10.1002/ijc.31294. Epub 2018 Feb 23.

PMID:
29405297
17.

HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005.

Félix A, Alemany L, Tous S, de Sanjosé S, Bosch FX.

Papillomavirus Res. 2016 Dec;2:41-45. doi: 10.1016/j.pvr.2016.02.003. Epub 2016 Mar 2.

18.

Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

Mena M, Lloveras B, Tous S, Bogers J, Maffini F, Gangane N, Kumar RV, Somanathan T, Lucas E, Anantharaman D, Gheit T, Castellsagué X, Pawlita M, de Sanjosé S, Alemany L, Tommasino M; HPV-AHEAD study group.

PLoS One. 2017 Oct 16;12(10):e0184520. doi: 10.1371/journal.pone.0184520. eCollection 2017.

19.

HPV prevalence in vulvar cancer in Austria.

Pils S, Gensthaler L, Alemany L, Horvat R, de Sanjosé S, Joura EA.

Wien Klin Wochenschr. 2017 Nov;129(21-22):805-809. doi: 10.1007/s00508-017-1255-2. Epub 2017 Sep 7.

20.

"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".

Rakislova N, Clavero O, Alemany L, Saco A, Quirós B, Lloveras B, Alejo M, Pawlita M, Quint W, Del Pino M, de Sanjose S, Ordi J; VVAP study group.

Int J Cancer. 2017 Dec 15;141(12):2517-2527. doi: 10.1002/ijc.31006. Epub 2017 Aug 31.

Supplemental Content

Loading ...
Support Center